New hope to stop deadly skin Cancer's return
NCT ID NCT02362594
Summary
This study tested whether a drug called pembrolizumab, given after surgery, could help prevent melanoma skin cancer from coming back in high-risk patients. Over 1,000 participants who had their cancer surgically removed were randomly assigned to receive either the drug or a placebo. The main goal was to see if the drug could extend the time patients lived without their cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.